-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

503. Clonal Hematopoiesis, Aging and Inflammation: Poster II

Symposia: Clonal Hematopoiesis, Aging and Inflammation Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 10, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Ing Soo Tiong, FRACP, FRCPA, MPhil1,2,3, Tamia Nguyen4,5*, Charis Teh, MPH, PhD6,7*, Chong Chyn Chua, MBBS, FRACP, FRCPA, PhD1,6,8, Sarah Ftouni, BSc, MSc4*, Thomas E Lew, MBBS9,10*, Fiona C. Brown, PhD11,12*, Donia Moujalled, PhD13*, Christine Muttiah, MBBS, FRACP, MPhil13*, Daniel Gray, PhD6*, Mary Ann Anderson, MBBS, PhD, FRACP, FRCPA9,10*, Philip A. Thompson, MBBS14*, Constantine S. Tam, MD, MBBS1, John F. Seymour, MBBS, PhD, FRACP15, Sarah-Jane Dawson, MBBS, FRACP, PhD3,5*, Andrew H. Wei, MBBS, PhD11,16, Geoffrey Lindeman13,17* and Piers Blombery, MBBS18,19

1The Alfred Hospital and Monash University, Melbourne, VIC, Australia
2Austin Health and Olivia Newton John Cancer Research Institute, Melbourne, Australia
3Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
4Peter MacCallum Cancer Centre, Melbourne, Australia
5The University of Melbourne, Parkville, Australia
6The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
7Department of Medical Biology, The University of Melbourne, Melbourne, Australia
8Northern Hospital, Epping, VIC, Australia
9Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia
10The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia
11The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
12Australian Centre for Blood Diseases, Monash University, Melbourne, Australia
13The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia
14Peter MacCallum Cancer Center, Royal Melbourne Hospital and University of Melbourne, Melbourne, Australia
15Peter MacCallum Cancer Center, Royal Melbourne Hospital and University of Melbourne, Melbourne, VIC, Australia
16Peter Maccallum Cancer Centre, Melbourne, VIC, Australia
17Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Australia
18Peter Maccallum Cancer Centre, East Melbourne, VIC, Australia
19Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia

Robert Vanner, MD, PhD1, Andy G.X. Zeng1, Michelle Chan-Seng-Yue, BSc1*, Suraj Bansal1*, Elisa Donato, PhD2*, Liqing Jin, MD1*, Sofia Genta, MD1*, Enrique Sanz Garcia, MD1*, Steven M. Chan, MD, PhD1, Andreas Trumpp2 and John E. Dick, PhD1

1Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
2HI-STEM gGmbH, Heidelberg, Germany

Rosalie Griffin, PhD1,2, Aswin Sekar, MD, PhD3, Sameer A. Parikh, MD4, Giulio Genovese5*, Dennis P. Robinson, PhD6*, Aaron D. Norman2*, Janet E. Olson, PhD2*, Kari G. Rabe, MS6*, Nicholas J. Boddicker, PhD1, Paul J. Hampel, MD7, Neil E. Kay, MD8,9, Timothy G. Call, MD9, James R. Cerhan, MD, PhD10, Esteban Braggio, PhD11, Curtis A. Hanson, MD12*, Caline M. Vachon, PhD2, Tait D. Shanafelt, MD13, Benjamin L. Ebert, MD, PhD14 and Susan L. Slager, PhD9,10

1Division of Computational Biology, Mayo Clinic, Rochester, MN
2Division of Epidemiology, Mayo Clinic, Rochester, MN
3Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
4Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
5Department of Genetics, Harvard Medical School, Boston, MA
6Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN
7Mayo Clinic, Rochester, MN
8Department of Immunology, Mayo Clinic, Rochester, MN
9Division of Hematology, Mayo Clinic, Rochester, MN
10Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
11Department of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ
12Department of Laboratory Medicine and Pathology, Division of Hematopathology, Mayo Clinic, Rochester, MN
13Department of Medicine, Division of Hematology, Stanford University, Stanford, CA
14Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Olisaemeka Ogbue1, Tariq Kewan, MBBChir2, Omar Mehkri3*, Francois Fadell3*, Ishani Nautiyal, BS1*, Megan Reynold1*, Arda Durmaz, PhD1*, Jennifer VanOudenhove, PhD2, Hussein Awada1*, Serhan Unlu, MD1*, Abhay Singh, MD, MPH4, Valeria Visconte, PhD1, Lourdes Mendez, MD2*, David S. Bosler, MD5*, Abhijit Duggal3*, Stephanie Halene, MD2, Jaroslaw P. Maciejewski, M.D., Ph.D., FACP1, Mohammed J Al-Jaghbeer,3* and Carmelo Gurnari, MD1,6

1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2Yale Cancer Center, Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
3Department of Pulmonary and Critical Care Medicine, Respiratory institute, Cleveland Clinic, Cleveland, OH
4Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
5Pathology and Laboratory Medicine Institute (Robert J. Tomsich), Cleveland, OH
6Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy

Raffaella Molteni, PhD1,2,3*, Martina Fiumara, MSc3,4,5*, Corrado Campochiaro, MD1*, Alessandro Tomelleri, MD1*, Elisa Diral, MD6*, Angelica Varesi, MSc7*, Alessandra Weber, MD1,5*, Davide Stefanoni, PhD2*, Roberta Alfieri, PhD8*, Luisa Albano, MSc7*, Maddalena Panigada, PhD2*, Eleonora Cantoni, MSc2*, Daniele Canarutto, MD, PhD9,10*, Luca Basso-Ricci, MSc5*, Pamela Quaranta, PhD5*, Angelo D'Alessandro, PhD11, Marco Matucci-Cerinic, MD12*, Raffaella Di Micco5*, Serena Scala, PhD5*, Alessandro Aiuti, MD, PhD1,5,10*, Fabio Ciceri1,13*, Ivan Merelli, PhD5,8*, Lorenzo Dagna, MD1*, Simone Cenci, MD1*, Giulio Cavalli, MD, PhD1,2,12,14*, Luigi Naldini, MD, PhD1,14 and Samuele Ferrari, PhD5,14

1Vita-Salute San Raffaele University, Milan, Italy
2Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan, Italy
3co-first author, Milan, Italy
4Vita-Salute San Raffaele University, Milan, ITA
5San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy
6Unit of Hematology and Stem Cell Transplantation, IRCCS San Raffaele Scientific Institute, Milan, Italy
7San Raffaele Telethon Institute For Gene Therapy, IRCCS San Raffaele Scientific, Milan, Italy
8Institute for Biomedical Technologies, National Research Council, Segrate, Italy
9San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Italiy, Italy
10Pediatric Immunohematology Unit and BMT Program, IRCCS San Raffaele Scientific Institute, Milan, Italy
11Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO
12Unit of Immunology, Rheumatology, Allergy and Rare diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy
13Unit of Hematology and Stem Cell Transplantation, Ospedale San Raffaele, University Vita-Salute San Raffaele, Milan, Italy
14co-last author, Milan, Italy

Daniel C. Cole1, Zhengrui Xiao, MD2, Varun Gupta3*, Jesus D. Anampa Mesias, MD4*, Noelle Townsend5*, Gretchen Mackie5*, Ami Sanghvi3*, Rahul Thakur, MBBS6, Herbert Lachman, MD3* and Irina Murakhovskaya, MD7

1Albert Einstein College of Medicine - Montefiore Medical Center, Bronx, NY
2Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
3Albert Einstein College of Medicine, Bronx, NY
4Montefiore Medical Ctr./Albert Einstein College of Medicine, Bronx, NY
5Division of Hematology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY
6Department of Medicine, Jacobi Medical Center/Albert Einstein College of Medicine, Bronx, NY
7Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY

Shweta Singh, PhD1, Tanmoy Sarkar, PhD1, Holly Morris1*, Kristbjorn Gudmundsson, PhD1,2* and Jonathan Keller, PhD1,2

1Mouse Cancer Genetics Program - Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD
2Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD

Tran Bich Nguyen, MD, PhD1*, Ai Nhan Thi Le2*, YuanJiao Duan2*, Yoshiaki Abe3,4*, Yen Nguyen4*, Mizuho Nakayama5*, Masanobu Oshima5*, Yuya Sasaki3,4*, Tatsuhiro Sakamoto3,4*, Manabu Fujisawa3,6*, Shigeru Chiba3,4* and Mamiko Sakata-Yanagimoto3,4,7

1Department of Hematology, Institute of Medicine, University of Tsukuba, Tsukuba, IBA, Japan
2Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan
3Department of Hematology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan
4Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan
5Division of Genetics, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
6Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, Canada
7Division of Advanced Hemato-Oncology, Transborder Medical Research Center, University of Tsukuba, Tsukuba, Japan

Monique Chavez, BS1*, Sridhar N Srivatsan2*, Christopher A Miller, PhD3*, Andrew J. Menssen, PhD4, Ajay Khanna5*, Jin Shao6*, Catrina Fronick7*, Robert Fulton8*, Sharon E Heath9*, Constantine Logothetis, MD10, Tasha Burton9*, Victoria Donaldson9*, Claudia Cabrera, BS11, Raya Saba, MD, MS12, Kiran R. Vij13, Eric J. Duncavage14*, Meagan Jacoby15* and Matthew J. Walter, MD16

1Department of Medicine, Division of Oncology, Washington University In St. Louis School of Medicine, Saint Louis, MO
2Washington University in St. Louis, St. Louis, MO
3Department of Internal Medicine, Division of Oncology, Section of Stem Cell Biology, Washington University in St. Louis School of Medicine, Saint Louis, MO
4Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO
5Washington University In St Louis, Saint Louis, MO
6Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO
7McDonnell Genome Institute, Washington University School of Medicine, St. Louis, Missouri, Saint Louis, MO
8McDonnell Genome Institute, St Louis, MO
9Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO
10Washington University, Saint Louis, MO
11Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
12Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, Kansas City, MO
13Washington University School of Medicine, Saint Louis, MO
14Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO
15Washington University-School of Medicine, St. Louis, MO
16Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO

Konradin F. Müskens, MD, MSc, MA1*, Maaike G.J.M. van Bergen, PhD2*, Aniek O. de Graaf, PhD2*, Nienke Wieringa, MD3*, Brigit M. te Pas4*, Anne P.J. de Pagter, MD PhD5*, Joëll E. Bense, MD PhD5*, Arjan C. Lankester, MD PhD5*, Leontien C.M. Kremer, MD PhD3*, Joop H. Jansen, PhD2*, Gerwin A. Huls, Prof.6, Stefan Nierkens, PhD3*, Caroline A. Lindemans, MD PhD3,7 and Mirjam E. Belderbos, MD, PhD3

1Princess Máxima Center for Pediatric Oncology, UTRECHT, Netherlands
2Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Nijmegen, Netherlands
3Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
4Princess Maxima Centre for Pediatric Oncology, Utrecht, Netherlands
5Division of Stem cell Transplantation, Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, Netherlands
6Department of Hematology, University Medical Center Groningen, Groningen, Netherlands
7Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands

Emil Hiitola1,2*, Juuso Korhonen1,2*, Jukka Koskela3*, Matti Kankainen1,2*, Milla Alakuijala1,2*, Heidi Kokkonen4*, Aoxing Liu3*, Paavo Häppölä3*, Paula Savola1,2,5*, Tiina Kelkka1,2*, Marjatta Leirisalo-Repo6*, Ritva Peltomaa6*, Laura Pirilä7*, Pia Isomäki8*, Markku Kauppi9,10*, Oili Kaipiainen-Seppänen11*, FinnGen Consortium12*, Giulio Genovese13,14,15*, Andrea Ganna3*, Solbritt Rantapää-Dahlqvist4*, Satu Mustjoki, MD, PhD1,2 and Mikko Myllymäki, M.D., Ph.D.1,2

1Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
2Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland
3Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland
4Department of Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå, Sweden
5Department of Clinical Chemistry, HUS Diagnostic Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
6Inflammation Center, Department of Rheumatology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
7Center for Rheumatology and Clinical Immunology, Turku University Hospital, Turku, Finland
8Molecular Immunology Group, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
9Päijät-Häme Central Hospital, Lahti, Finland
10Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland
11Kuopio Univerisity Hospital, Kuopio, Finland
12University of Helsinki, Helsinki, Finland
13Department of Genetics, Harvard Medical School, Boston, MA
14Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Cambridge, MA
15Stanley Center, Broad Institute of Harvard and MIT, Cambridge, MA

Peter Geon Kim, MD1*, Christopher B. Hergott, MD, PhD2*, Justin CT Loke, MD PhD1, Wesley Shin1*, Marie E McConkey, PhD1* and Benjamin L. Ebert, MD, PhD3,4,5

1Dana Farber Cancer Institute, Boston, MA
2Dana-Farber Cancer Institute, Boston, MA
3Broad Institute of MIT and Harvard University, Cambridge, MA
4Howard Hughes Medical Institute, Boston, MA
5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

*signifies non-member of ASH
  翻译: